BBHC
ACAD icon

Brown Brothers Harriman & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-106
Closed -$3K – 792
2017
Q4 		$3K Buy
+106
New +$3.39K ﹤0.01% 926
2017
Q1 		– Sell
-110
Closed -$3K – 790
2016
Q4 		$3K Hold
110
– – ﹤0.01% 808
2016
Q3 		$3K Hold
110
– – ﹤0.01% 724
2016
Q2 		$4K Buy
+110
New +$3.68K ﹤0.01% 727

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return